Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
2.790
-0.300 (-9.71%)
At close: Nov 6, 2026, 4:00 PM EST
2.800
+0.010 (0.36%)
After-hours: Nov 6, 2026, 7:30 PM EST
Nephros Market Cap
Nephros has a market cap or net worth of $30.3 million as of November 6, 2026. It is the 33,617th most valuable company in the world and the 4,925th biggest in the United States. Its market cap has decreased by 49.75% in one year.
Market Cap
30.30M
Enterprise Value
26.53M
1-Year Change
-49.75%
Global Rank
Country Rank
#4,925 United States
Category
ChartMarket Cap Chart
Since September 30, 2004, Nephros's market cap has decreased from $62.30M to $30.30M, a decrease of -51.36%. That is a compound annual growth rate of -3.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 30.30M | -41.62% |
| Dec 31, 2025 | 51.90M | 234.84% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 116.39% |
| Dec 31, 2018 | 36.60M | 49.39% |
| Dec 29, 2017 | 24.50M | 36.11% |
| Dec 30, 2016 | 18.00M | 85.57% |
| Dec 31, 2015 | 9.70M | -51.50% |
| Dec 31, 2014 | 20.00M | 163.16% |
| Dec 31, 2013 | 7.60M | -44.93% |
| Dec 31, 2012 | 13.80M | 91.67% |
| Dec 30, 2011 | 7.20M | 71.43% |
| Dec 31, 2010 | 4.20M | -87.08% |
| Dec 31, 2009 | 32.50M | 622.22% |
| Dec 31, 2008 | 4.50M | -27.42% |
| Dec 31, 2007 | 6.20M | -65.36% |
| Dec 29, 2006 | 17.90M | 1.13% |
| Dec 30, 2005 | 17.70M | -69.22% |
| Dec 31, 2004 | 57.50M | -7.70% |
| Sep 30, 2004 | 62.30M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stereotaxis | 105.21M |
| Precision Optics Corporation | 54.32M |
| Daxor | 50.38M |
| Harvard Bioscience | 38.51M |
| Davion Healthcare | 32.75M |
| Milestone Scientific | 26.54M |
| Retractable Technologies | 16.94M |
| Bionano Genomics | 12.96M |